1. Division of Infectious Disease and International Medicine, Department of Internal Medicine
2. Clinical and Translational Science Institute, University of Minnesota, Minneapolis
3. Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts